Beamr video compression achieves up to 50% improvement for AVs
LONDON - Advanced Medical (TASE:BLWV) Solutions Group plc (AIM:AMS (VIE:AMS2)), a specialist in tissue-healing technologies, announced Monday that all resolutions were approved at its Annual General Meeting held in London.
Shareholders representing approximately 62% of the company’s voting capital participated in the meeting, with most resolutions receiving overwhelming support. The approval of the company’s financial statements received unanimous support with 100% of votes cast in favor.
Other key resolutions that passed included the remuneration report (98.47% approval), auditor remuneration (98.61%), and a final dividend (100%). The company also received shareholder approval for special resolutions regarding share allotment (99.50%), pre-emption rights (98.78%), and share purchase authorization (99.98%).
Board members receiving re-election included G. Cook (93.38% approval), D. Le Fort (94.36%), C. Meredith (NYSE:MDP) (98.87%), and E. Johnson (98.39%). S. Searle was newly elected to the board with 99.96% support.
The meeting took place at the offices of Investec (LON:INVP) Bank plc in London. The notice of the meeting had been previously sent to shareholders on June 3, 2025.
Advanced Medical Solutions, based in Winsford, UK, develops and manufactures tissue-healing technology with operations across multiple countries including the UK, Germany, France, Israel, and others.
The information about the AGM results was provided in a company press release.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.